Kymera Therapeutics, Inc. (KYMR) Insider Trading

Name: Kymera Therapeutics, Inc. (KYMR) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 1, 2026): Nello Mainolfi (Chief Executive Officer): Exercise/Conversion of 30,000 shares, $62.4K.

Get alerted when insiders trade KYMR

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta